The Role of Oxidative Stress in the Development of Cisplatin Resistance in Epithelial Ovarian Cancer

被引：0
|
作者：
Jimmy Belotte
Nicole M. Fletcher
Awoniyi O. Awonuga
Mitchell Alexis
Husam M. Abu-Soud
Mohammed G. Saed
Michael P. Diamond
Ghassan M. Saed
机构：
[1] Wayne State University School of Medicine,Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development
[2] Wayne State University School of Medicine,Office of Graduate Scholars
[3] Georgia Regents University,Department of Obstetrics and Gynecology
来源：
Reproductive Sciences | 2014年 / 21卷
关键词：
epithelial ovarian cancer; cisplatin resistance; reactive oxygen species;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：503 / 508
页数：5
相关论文
共 50 条
  • [31] Understanding the biological role of MMP16 in cisplatin resistance in ovarian cancer
    Bonilla-Liriano, Jesennia
    Rivera-Serrano, Mariela
    Reyes-Burgos, Victor
    Rolon-Perez, Jose
    Valiyeva, Fatima
    Vivas-Mejia, Pablo
    CANCER RESEARCH, 2024, 84 (06)
  • [32] The role of Rho GTPase in cell stiffness and cisplatin resistance in ovarian cancer cells
    Sharma, Shivani
    Santiskulvong, Chintda
    Rao, Jianyu
    Gimzewski, James K.
    Dorigo, Oliver
    INTEGRATIVE BIOLOGY, 2014, 6 (06) : 611 - 617
  • [33] Human ovarian cancer and cisplatin resistance: Possible role of inhibitor of apoptosis proteins
    Li, JL
    Feng, Q
    Kim, JM
    Schneiderman, D
    Liston, P
    Li, M
    Vanderhyden, B
    Faught, W
    Fung, MFK
    Senterman, M
    Korneluk, RG
    Tsang, BK
    ENDOCRINOLOGY, 2001, 142 (01) : 370 - 380
  • [34] Calcium homeostasis in cisplatin resistant epithelial ovarian cancer
    Kucukkaya, Bahire
    Basoglu, Harun
    Erdag, Demet
    Akbas, Fahri
    Susgun, Seda
    Yalcintepe, Leman
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2019, 38 (04) : 353 - 363
  • [35] Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer
    Kim, Myung Joo
    Jung, Yong Wook
    Seong, Seok Ju
    Yoon, Bo Sung
    Kim, Mi La
    Joo, Won Deok
    Song, Tae Jong
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2012, 23 (02) : 91 - 97
  • [36] Molecular mechanisms of cisplatin resistance in ovarian cancer
    Jiang, Chenying
    Shen, Chenjun
    Ni, Maowei
    Huang, Lili
    Hu, Hongtao
    Dai, Qinhui
    Zhao, Huajun
    Zhu, Zhihui
    GENES & DISEASES, 2024, 11 (06)
  • [37] Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
    Zhao, Yujie
    Hong, Xiaoting
    Chen, Xiong
    Hu, Chun
    Lu, Weihong
    Xie, Baoying
    Zhong, Linhai
    Zhang, Wenqing
    Cao, Hanwei
    Chen, Binbin
    Liu, Qian
    Zhan, Yanyan
    Xiao, Li
    Hu, Tianhui
    CANCERS, 2021, 13 (14)
  • [38] Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer
    Zhao, Henan
    Liu, Sha
    Wang, Guano
    Wu, Xian
    Ding, Yanfang
    Guo, Gordon
    Jiang, Jiyong
    Cui, Shiying
    ONCOLOGY REPORTS, 2015, 33 (02) : 591 - 598
  • [39] Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells
    Luo, Yanwei
    Gui, Rong
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (05) : 1 - 16
  • [40] Low expression of FXYD5 reverses the cisplatin resistance of epithelial ovarian cancer cells
    Liu, Ya-Kun
    Jia, Ya-Jing
    Liu, Shi-Hao
    Shi, Hong-Jie
    Ma, Jing
    HISTOLOGY AND HISTOPATHOLOGY, 2021, 36 (05) : 535 - 545
12345